Kim Stanton
Overview
Explore the profile of Kim Stanton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vindedzis S, Marsh B, Sherriff J, Dhaliwal S, Stanton K
Diabetes Ther
. 2013 Apr;
4(1):67-75.
PMID: 23580229
Introduction: Guidelines for self-treatment of hypoglycaemia specify initial treatment with quick-acting carbohydrate until blood glucose levels normalize and then follow-up with longer-acting carbohydrate. The few studies investigating follow-up show 29-57%...
2.
Ting R, Keech A, Drury P, Donoghoe M, Hedley J, Jenkins A, et al.
Diabetes Care
. 2012 Jan;
35(2):218-25.
PMID: 22210576
Objective: Diabetic patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] 30-59 mL/min/1.73 m(2)) are at particular cardiovascular risk. Fenofibrate's safety in these patients is an issue because it...
3.
Effect of lowering tumour necrosis factor-alpha on vascular endothelial function in Type II diabetes
Bilsborough W, ODriscoll G, Stanton K, Weerasooriya R, Dembo L, Taylor R, et al.
Clin Sci (Lond)
. 2002 Aug;
103(2):163-9.
PMID: 12149108
Tumour necrosis factor-alpha (TNF alpha) is a mediator of reactive oxygen species, which are implicated in endothelial dysfunction and atherosclerosis. Type II diabetes is associated with endothelial dysfunction and elevated...